CVM
GILD icon

Cheviot Value Management’s Gilead Sciences GILD Stock Holding History

Cheviot Value Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.1K Buy
737
+5
+0.7% +$659 0.01% 172
2026
Q1 		$102K Buy
732
+4
+0.5% +$560 0.01% 159
2025
Q4 		$102K Buy
728
+5
+0.7% +$608 0.01% 165
2025
Q3 		$85.3K Buy
723
+5
+0.7% +$568 0.01% 187
2025
Q2 		$85.8K Sell
718
-45
-6% -$4.79K 0.01% 168
2025
Q1 		$78.4K Buy
+763
New +$78.7K 0.01% 166

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cheviot Value Management's GILD Position: Q2 2026 in Review

Cheviot Value Management increased its Gilead Sciences (GILD) stake by 0.68% in Q2 2026, buying an estimated $659 and bringing the position to 737 shares worth $93.1K. The position accounts for 0.01% of the portfolio, ranked #172.

Cheviot Value Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $102K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cheviot Value Management held 737 shares of Gilead Sciences worth $93.1K as of Q2 2026.
  • Cheviot Value Management bought 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.01% of Cheviot Value Management's portfolio in Q2 2026, its #172 holding.
  • Cheviot Value Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Cheviot Value Management's Gilead Sciences position peaked at $102K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.